Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease

Lupus

Volumn 22, Issue 13, 2013, Pages 1371-1381

  Mesa, A ^a   Somarelli, J A ^b   Wu, W ^a   Martinez, L ^c   Blom, M B ^c   Greidinger, E L ^c   Herrera, R J ^d  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

autoimmune disorders; classification criteria; immunoglobulin M (IgM); mixed connective tissue disease (MCTD); Systemic lupus erythematosus (SLE); U1 small nuclear ribonucleoprotein particle (U1 snRNP)

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ANTIGENICITY; ARTICLE; CARDIOVASCULAR SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISORDERS; CLASSIFICATION CRITERIA; IMMUNOGLOBULIN M (IGM); MIXED CONNECTIVE TISSUE DISEASE (MCTD); SYSTEMIC LUPUS ERYTHEMATOSUS (SLE); U1 SMALL NUCLEAR RIBONUCLEOPROTEIN PARTICLE (U1 SNRNP);

AREA UNDER CURVE; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIXED CONNECTIVE TISSUE DISEASE; PREDICTIVE VALUE OF TESTS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; ROC CURVE;

EID: 84887089456     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313508444     Document Type: Article

References (42)

1. Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumatology (Oxford). 2005 ; 44: 975-982
2. Liu CC, Ahearn JM. The search for lupus biomarkers. Best Pract Res Clin Rheumatol. 2009 ; 4: 507-523
3. Zdrojewicz Z, Budzyń-Kozioł E, Puławska J. Mixed connective tissue disease - etiology, pathogenesis, clinical significance, treatment [in Polish]. Postepy Hig Med Dosw. 1999 ; 53: 751-766
4. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clinical Pathol. 2000 ; 53: 424-432
5. Greidinger EL, Hoffman RW. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens. Arthritis Rheum. 2001 ; 44: 368-375
6. Neogi T, Gladman DD, Ibañez D, Urowitz M. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. J Rheumatol. 2006 ; 33: 1785-1788
7. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 ; 52: 148-159
8. López-Longo FJ, Fernández J, Monteagudo I, et al. Clinical and serologic course of patients with mixed connective tissue disease [in Spanish]. Rev Clin Esp. 1994 ; 194: 682-688
9. Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am. 2005 ; 31: 411-420
10. Swanton J, Isenberg D. Mixed connective tissue disease: Still crazy after all these years. Rheum Dis Clin North Am. 2005 ; 31: 421-436
11. Venables PJ. Mixed connective tissue disease. Lupus. 2006 ; 15: 132-137
12. von Bierbrauer A, Willert J, Barth P. Histomorphometrical analysis of microvascular abnormalities in connective tissue diseases. Rheumatol Int. 2008 ; 28: 253-259
13. Nowicka-Sauer K, Czuszynska Z, Majkowicz M, et al. Neuropsychological assessment in mixed connective tissue disease: Comparison with systemic lupus erythematosus. Lupus. 2012 ; 21: 927-933
14. Hochberg MC. Updating the America College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
15. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-dsDNA antibodies: Are we approaching journey's end?. Rheumatology (Oxford). 2007 ; 46: 1052-1056
16. Breda L, Nozzi M, De Sanctis S, Chiarelli F. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: An update. Semin Arthritis Rheum. 2010 ; 4: 53-72
17. Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for MCTD in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol. 1996 ; 12: 2055-2062
18. Reveille JD. Predicted value of antibodies for activity of systemic lupus erythematosus. Lupus. 2004 ; 5: 290-297
19. Perkins K, Hoffman RW, Bezruczko N. A Rasch analysis for classification of systemic lupus erythematosus and mixed connective tissue disease. J Appl Meas. 2008 ; 9: 136-150
20. Hoffman RW, Bezruczko N, Perkins K. An external validation study of a classification of mixed connective tissue disease and systemic lupus erythematosus patients. J Appl Meas. 2012 ; 13: 205-216
21. Mahler M, Stinton LM, Fritzler MJ. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay. Clin Diagn Lab Immunol. 2005 ; 1: 107-113
22. Chiaro TR, Davis KW, Wilson A, Suh-Lailam B, Tebo AE. Significant differences in the analytic concordance between anti-dsDNA IgG antibody assays for the diagnosis of systemic lupus erythematosus - implications for inter-laboratory testing. Clin Chim Acta. 2011 ; 412: 1076-1080
23. Hoet RM, Kastner B, Lührmann R, van Venrooij WJ. Purification and characterization of human auto-antibodies directed to specific regions on U1RNA; recognition of native U1RNP complexes. Nucleic Acids Res. 1993 ; 21: 5130-5136
24. Vlachoyiannopoulos PG, Guialis A, Tzioufas AG, Moutsopoulos HM. Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus. Br J Rheumatol. 1996 ; 35: 534-541
25. Mesa A, Somarelli JA, Herrera RJ. Spliceosomal immunophilins. FEBS Lett. 2008 ; 582: 2345-2351
26. Buratti E, Baralle D. Novel roles of U1 snRNP in alternative splicing regulation. RNA Biol. 2010 ; 7: 412-419
27. Somarelli JA, Mesa A, Roy A, Zhang Y, Herrera RJ. A three-dimensional model of the U1 small nuclear ribonucleoprotein particle. Entomol Res. 2010 ; 40: 104-112
28. Luyckx A, Westhoven R, Oris E, Papisch W, Bossuyt X. Clinical relevance of measurement of antibodies to individual snU1 RNP proteins. Clin Chem. 2005 ; 51: 1888-1890
29. Witte T, Hartung K, Sachse C, et al. IgM anti-dsDNA antibodies in systemic lupus erythematosus: Negative association with nephritis SLE Study Group. Rheumatol Int. 1998 ; 18: 85-91
30. Zhang W, Reichlin M. IgM anti-A and D SnRNP proteins and IgM anti-dsDNA are closely associated in SLE sera. Clin Immunol Immunopathol. 1995 ; 74: 70-76
31. Palafox Sánchez CA, Satoh M, Chan EK, et al. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies. Arthritis Res Ther. 2009 ; 11: R27 - R27
32. Somarelli JA, Mesa A, Rodriguez R, et al. Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease. Lupus. 2011 ; 20: 274-289
33. Paredes JCM, Oliveira LG, de Carvalho Braga A, Trevisol IM, Roehe PM. Development and standardization of an indirect ELISA for the serological diagnosis of classical swine fever. Pesq Vet Bra. 1999 ; 19: 123-127
34. Fries LF, Mullins WW, Cho KR, Plotz PH, Frank MM. Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosus. J Immunol. 1984 ; 132: 695-700
35. Nishimaki T, Aotsuka S, Kondo H, et al. Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol. 1999 ; 26: 2357-2362
36. Lindorfer MA, Schuman TA, Craig ML, Martin EN, Taylor RP. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus. J Immunol Methods. 2001 ; 248: 125-138
37. Routsias JG, Kyriakidis N, Latreille M, Tzioufas AG. RNA recognition motif (RRM) of La/SSB: The bridge for interparticle spreading of autoimmune response to U1-RNP. Mol Med. 2010 ; 16: 19-26
38. Ryu HJ, Takeuchi F, Kuwata S, et al. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis. Rheumatol Int. 2011 ; 31: 315-319
39. Pollard KM, Tan EM. Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody. Clin Exp Immunol. 1985 ; 60: 586-596
40. Kingsmore SF, Thompson JM, Crockard AD, et al. Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: Correlation with disease activity in patients with systemic lupus erythematosus. J Clin Lab Immunol. 1989 ; 30: 45-52
41. Hopkinson ND, Doherty M, Powel RJ. Clinical features and race specific incident/prevalence rates of systemic lupus erythematosus in geographically complete cohort of patients. Ann Rheum Dis. 1994 ; 53: 675-680
42. Weiss JE. Pediatric systemic lupus erythematosus: More than a positive antinuclear antibody. Pediatr Rev. 2012 ; 33: 62-73